LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 2.66 | 84.90 | 629 | 285 | 2.2013 | 2.1387 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 2.66 | 84.90 | 543 | 285 | 1.9003 | 1.8859 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 4.36 | 84.90 | 725 | 322 | 2.2476 | 2.0455 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 4.36 | 84.90 | 623 | 322 | 1.9314 | 1.8149 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 6.06 | 84.90 | 837 | 365 | 2.2903 | 1.9643 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 6.06 | 84.90 | 1 | 365 | 0.0027 | -0.8787 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 6.06 | 84.90 | 685 | 365 | 1.8744 | 1.6952 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 7.77 | 84.90 | 869 | 411 | 2.1131 | 1.7783 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 7.77 | 84.90 | 1 | 411 | 0.0024 | -0.8579 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 7.77 | 84.90 | 754 | 411 | 1.8335 | 1.6103 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 9.47 | 84.90 | 963 | 447 | 2.1523 | 1.7534 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 9.47 | 84.90 | 1 | 447 | 0.0022 | -0.8431 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 9.47 | 84.90 | 853 | 447 | 1.9064 | 1.6175 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 11.18 | 84.90 | 1 | 492 | 0.0020 | -0.8265 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 11.18 | 84.90 | 1070 | 492 | 2.1732 | 1.7162 | MN20160318_Q02 | G05 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 11.18 | 84.90 | 1 | 492 | 0.0020 | -0.8265 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 11.18 | 84.90 | 948 | 492 | 1.9254 | 1.5896 | MN20160318_Q02 | H08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.00043333 | 12.88 | 84.90 | 7 | 531 | 0.0132 | -0.6107 | MN20160318_Q02 | G05 |